Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Should we screen BRCA1 mutation carriers only with MRI? A multicenter study.

Breast cancer research and treatment - 1 Apr 2014

Obdeijn Inge-Marie, Winter-Warnars Gonneke A O, Mann Ritse M, Hooning Maartje J, Hunink M G Myriam, Tilanus-Linthorst Madeleine M A

Abstract excerpt

BRCA1 mutation carriers are offered screening with MRI and mammography. Aim of the study was to investigate the additional value of digital mammography over MRI screening. BRCA1 mutation carriers, who developed breast cancer since the introduction of digital mammography between January 2003 and March 2013, were included. The images and reports were reviewed in order to assess whether the breast cancers were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Early Detection of Cancer
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mammography

Share to Neoplasm Grading

Share to Neoplasm Metastasis

Share to Neoplasm Staging

Share to Sensitivity and Specificity

Share to Tumor Burden

Source

Identifiers

PMID: 24567197
DOI: 10.1007/s10549-014-2888-8

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Should we screen BRCA1 mutation carriers only with MRI? A multicenter study.PMID 24567197Read ↗

The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers.Semantic proximity Read ↗

Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.Semantic proximity Read ↗

The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.Semantic proximity Read ↗

Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program.Semantic proximity Read ↗

Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence.Semantic proximity Read ↗

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).Semantic proximity Read ↗

Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis.Semantic proximity Read ↗

Five-year analysis of magnetic resonance imaging as a screening tool in women at hereditary risk of breast cancer.Semantic proximity Read ↗

Characteristics, treatment, and outcome of breast cancers diagnosed in BRCA1 and BRCA2 gene mutation carriers in intensive screening programs including magnetic resonance imaging.Semantic proximity Read ↗

Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer.Semantic proximity Read ↗

Dynamic contrast-enhanced magnetic resonance imaging for risk-stratified screening in women with BRCA mutations or high familial risk for breast cancer: are we there yet?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.